Todd Hankinson
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 23 | 2025 | 77 | 8.680 |
Why?
| | Pituitary Neoplasms | 20 | 2025 | 190 | 6.770 |
Why?
| | Hydrocephalus | 20 | 2026 | 111 | 4.080 |
Why?
| | Arnold-Chiari Malformation | 14 | 2026 | 29 | 3.580 |
Why?
| | Brain Neoplasms | 29 | 2025 | 1318 | 3.320 |
Why?
| | Neurosurgical Procedures | 14 | 2024 | 202 | 3.180 |
Why?
| | Ventriculoperitoneal Shunt | 12 | 2026 | 44 | 1.930 |
Why?
| | Magnetic Resonance Imaging | 23 | 2026 | 3857 | 1.860 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 87 | 1.720 |
Why?
| | Ependymoma | 12 | 2026 | 176 | 1.720 |
Why?
| | Ganglioglioma | 5 | 2025 | 34 | 1.680 |
Why?
| | Decompression, Surgical | 10 | 2026 | 115 | 1.640 |
Why?
| | Child | 96 | 2026 | 22537 | 1.620 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 12 | 1.560 |
Why?
| | Infratentorial Neoplasms | 9 | 2026 | 71 | 1.540 |
Why?
| | Joint Instability | 7 | 2020 | 182 | 1.510 |
Why?
| | Glioma | 7 | 2025 | 425 | 1.480 |
Why?
| | Cerebrospinal Fluid Shunts | 11 | 2026 | 34 | 1.400 |
Why?
| | Spinal Injuries | 4 | 2022 | 58 | 1.360 |
Why?
| | Spinal Fusion | 9 | 2024 | 260 | 1.260 |
Why?
| | Child, Preschool | 50 | 2026 | 11774 | 1.230 |
Why?
| | Dura Mater | 4 | 2026 | 35 | 1.230 |
Why?
| | Syringomyelia | 6 | 2026 | 12 | 1.180 |
Why?
| | Pons | 4 | 2016 | 33 | 1.100 |
Why?
| | Occipital Bone | 5 | 2024 | 18 | 1.080 |
Why?
| | Cervical Atlas | 3 | 2024 | 3 | 1.060 |
Why?
| | Cervical Vertebrae | 10 | 2026 | 157 | 1.050 |
Why?
| | Xanthomatosis | 2 | 2017 | 8 | 1.040 |
Why?
| | Sella Turcica | 2 | 2017 | 17 | 1.040 |
Why?
| | Infant | 40 | 2026 | 10022 | 1.040 |
Why?
| | Ventriculostomy | 9 | 2026 | 24 | 1.030 |
Why?
| | Humans | 144 | 2026 | 144261 | 0.970 |
Why?
| | Neurosurgery | 4 | 2025 | 41 | 0.930 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2730 | 0.910 |
Why?
| | Neuroendoscopy | 6 | 2025 | 24 | 0.890 |
Why?
| | Postoperative Complications | 15 | 2026 | 2916 | 0.820 |
Why?
| | Infant, Newborn | 20 | 2026 | 6424 | 0.810 |
Why?
| | Adolescent | 50 | 2026 | 22281 | 0.810 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 5 | 0.800 |
Why?
| | Machine Learning | 5 | 2026 | 585 | 0.790 |
Why?
| | Neck Injuries | 1 | 2022 | 21 | 0.740 |
Why?
| | Third Ventricle | 5 | 2025 | 16 | 0.740 |
Why?
| | Neural Tube Defects | 4 | 2019 | 65 | 0.730 |
Why?
| | Male | 76 | 2026 | 72035 | 0.730 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 780 | 0.720 |
Why?
| | Cellular Senescence | 1 | 2024 | 226 | 0.700 |
Why?
| | Neuroprotection | 1 | 2022 | 46 | 0.700 |
Why?
| | SEER Program | 4 | 2018 | 224 | 0.680 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2026 | 1137 | 0.670 |
Why?
| | Female | 77 | 2026 | 77976 | 0.660 |
Why?
| | Transcriptome | 8 | 2025 | 1044 | 0.630 |
Why?
| | Retrospective Studies | 35 | 2026 | 17009 | 0.630 |
Why?
| | Reoperation | 7 | 2026 | 629 | 0.620 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 91 | 0.620 |
Why?
| | Perioperative Care | 2 | 2026 | 230 | 0.580 |
Why?
| | Down Syndrome | 2 | 2020 | 534 | 0.580 |
Why?
| | Pediatrics | 3 | 2025 | 1112 | 0.570 |
Why?
| | Brain Injuries, Traumatic | 3 | 2026 | 441 | 0.560 |
Why?
| | Infant, Premature | 2 | 2026 | 611 | 0.560 |
Why?
| | Atlanto-Occipital Joint | 3 | 2024 | 4 | 0.550 |
Why?
| | Treatment Outcome | 28 | 2026 | 11643 | 0.530 |
Why?
| | Pituitary Diseases | 1 | 2017 | 20 | 0.520 |
Why?
| | Meningioma | 1 | 2018 | 86 | 0.510 |
Why?
| | Decision Support Systems, Clinical | 3 | 2026 | 265 | 0.510 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 6 | 0.510 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 93 | 0.510 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 173 | 0.500 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 100 | 0.480 |
Why?
| | Skull | 1 | 2017 | 155 | 0.470 |
Why?
| | Cerebral Ventricles | 2 | 2022 | 54 | 0.470 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 18 | 0.460 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 17 | 0.460 |
Why?
| | Ketorolac | 1 | 2015 | 30 | 0.460 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 16 | 0.450 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 17 | 0.450 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2025 | 225 | 0.450 |
Why?
| | ErbB Receptors | 2 | 2016 | 627 | 0.450 |
Why?
| | Temporal Lobe | 1 | 2015 | 104 | 0.440 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 48 | 0.440 |
Why?
| | Neocortex | 2 | 2025 | 48 | 0.440 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 8 | 0.440 |
Why?
| | src-Family Kinases | 1 | 2015 | 93 | 0.430 |
Why?
| | Meningomyelocele | 3 | 2026 | 61 | 0.420 |
Why?
| | Data Collection | 2 | 2014 | 633 | 0.410 |
Why?
| | Professional Practice | 1 | 2014 | 57 | 0.400 |
Why?
| | Neurosurgeons | 3 | 2025 | 17 | 0.400 |
Why?
| | Delayed Diagnosis | 2 | 2024 | 94 | 0.390 |
Why?
| | Cerebral Hemorrhage | 2 | 2026 | 120 | 0.390 |
Why?
| | Spinal Cord Injuries | 3 | 2024 | 240 | 0.390 |
Why?
| | Quality of Life | 6 | 2026 | 3166 | 0.380 |
Why?
| | Scoliosis | 3 | 2024 | 223 | 0.380 |
Why?
| | Moyamoya Disease | 2 | 2014 | 20 | 0.380 |
Why?
| | Young Adult | 17 | 2021 | 13990 | 0.380 |
Why?
| | Neurology | 1 | 2014 | 110 | 0.370 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 338 | 0.370 |
Why?
| | Intracranial Pressure | 2 | 2026 | 65 | 0.370 |
Why?
| | Urethral Diseases | 1 | 2011 | 18 | 0.350 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 32 | 0.350 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 379 | 0.350 |
Why?
| | Societies, Medical | 2 | 2025 | 886 | 0.340 |
Why?
| | Genomics | 1 | 2016 | 833 | 0.340 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 41 | 0.330 |
Why?
| | Observer Variation | 2 | 2025 | 354 | 0.330 |
Why?
| | Brain Injuries | 1 | 2016 | 506 | 0.330 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 732 | 0.330 |
Why?
| | Follow-Up Studies | 11 | 2026 | 5389 | 0.330 |
Why?
| | Epilepsy | 2 | 2025 | 375 | 0.330 |
Why?
| | Cranial Sutures | 1 | 2010 | 16 | 0.330 |
Why?
| | Odontoid Process | 1 | 2010 | 5 | 0.320 |
Why?
| | Craniotomy | 2 | 2008 | 82 | 0.320 |
Why?
| | Cephalometry | 1 | 2010 | 30 | 0.320 |
Why?
| | Esthetics | 1 | 2010 | 41 | 0.320 |
Why?
| | Artificial Intelligence | 2 | 2025 | 365 | 0.320 |
Why?
| | Internal Fixators | 1 | 2010 | 32 | 0.310 |
Why?
| | Spinal Diseases | 1 | 2010 | 50 | 0.310 |
Why?
| | Brain Stem | 1 | 2010 | 95 | 0.300 |
Why?
| | Biomarkers, Tumor | 3 | 2024 | 1313 | 0.300 |
Why?
| | Craniosynostoses | 1 | 2010 | 68 | 0.300 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1455 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2024 | 309 | 0.300 |
Why?
| | Urinary Bladder | 1 | 2011 | 194 | 0.300 |
Why?
| | Surgeons | 1 | 2014 | 338 | 0.300 |
Why?
| | Patient Discharge | 1 | 2016 | 977 | 0.290 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.280 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 78 | 0.280 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 309 | 0.280 |
Why?
| | Neuroimaging | 3 | 2020 | 289 | 0.280 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 27 | 0.270 |
Why?
| | Insurance, Liability | 1 | 2008 | 8 | 0.270 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 22 | 0.270 |
Why?
| | RNA, Messenger | 2 | 2017 | 2829 | 0.270 |
Why?
| | Equipment Failure | 3 | 2026 | 115 | 0.270 |
Why?
| | Pyramidal Cells | 2 | 2025 | 79 | 0.270 |
Why?
| | Brain | 5 | 2023 | 2930 | 0.270 |
Why?
| | Surgical Wound Infection | 3 | 2022 | 316 | 0.270 |
Why?
| | Prognosis | 8 | 2026 | 4278 | 0.260 |
Why?
| | Medically Underserved Area | 1 | 2008 | 100 | 0.250 |
Why?
| | Adult | 20 | 2025 | 40262 | 0.250 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 264 | 0.250 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 241 | 0.250 |
Why?
| | Granuloma | 2 | 2017 | 96 | 0.250 |
Why?
| | Surgical Flaps | 1 | 2008 | 142 | 0.250 |
Why?
| | Astrocytoma | 2 | 2025 | 129 | 0.250 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 729 | 0.250 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2025 | 15 | 0.230 |
Why?
| | 4-Aminopyridine | 1 | 2025 | 30 | 0.230 |
Why?
| | Potassium Channel Blockers | 1 | 2025 | 47 | 0.230 |
Why?
| | Trastuzumab | 1 | 2026 | 118 | 0.230 |
Why?
| | Autophagy | 2 | 2019 | 285 | 0.230 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2026 | 41 | 0.230 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 358 | 0.230 |
Why?
| | Cranial Fossa, Posterior | 2 | 2026 | 20 | 0.230 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 161 | 0.220 |
Why?
| | Subdural Effusion | 1 | 2024 | 4 | 0.220 |
Why?
| | Interdisciplinary Communication | 1 | 2026 | 197 | 0.210 |
Why?
| | Infant, Premature, Diseases | 1 | 2026 | 111 | 0.210 |
Why?
| | Radiation Injuries | 2 | 2018 | 151 | 0.210 |
Why?
| | United States | 8 | 2025 | 15876 | 0.210 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 120 | 0.210 |
Why?
| | Macrophage Activation | 1 | 2025 | 193 | 0.210 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 8 | 0.210 |
Why?
| | Neuronavigation | 1 | 2024 | 8 | 0.210 |
Why?
| | Computational Biology | 3 | 2025 | 680 | 0.210 |
Why?
| | Clonal Evolution | 1 | 2024 | 47 | 0.210 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 32 | 0.200 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3403 | 0.200 |
Why?
| | Phagocytosis | 1 | 2025 | 299 | 0.200 |
Why?
| | Microarray Analysis | 4 | 2017 | 117 | 0.200 |
Why?
| | Drainage | 1 | 2024 | 185 | 0.200 |
Why?
| | Tumor Burden | 1 | 2024 | 319 | 0.200 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1264 | 0.190 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 1182 | 0.190 |
Why?
| | Cohort Studies | 8 | 2024 | 5935 | 0.190 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1983 | 0.190 |
Why?
| | Pineal Gland | 1 | 2022 | 15 | 0.190 |
Why?
| | Pinealoma | 1 | 2022 | 9 | 0.190 |
Why?
| | Germinoma | 1 | 2022 | 10 | 0.190 |
Why?
| | Nerve Net | 1 | 2025 | 285 | 0.190 |
Why?
| | Brain Concussion | 2 | 2022 | 638 | 0.190 |
Why?
| | Contrast Media | 1 | 2025 | 486 | 0.180 |
Why?
| | Cysts | 1 | 2023 | 111 | 0.180 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.180 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 197 | 0.180 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 17 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2025 | 748 | 0.180 |
Why?
| | Developing Countries | 1 | 2024 | 314 | 0.180 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 191 | 0.180 |
Why?
| | Software | 2 | 2025 | 690 | 0.170 |
Why?
| | Spine | 1 | 2023 | 182 | 0.170 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.170 |
Why?
| | beta Catenin | 2 | 2024 | 252 | 0.170 |
Why?
| | Endoscopy | 2 | 2015 | 315 | 0.170 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 162 | 0.170 |
Why?
| | Traction | 1 | 2021 | 19 | 0.170 |
Why?
| | Chromatin | 1 | 2025 | 561 | 0.170 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3539 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 964 | 0.160 |
Why?
| | Disease Progression | 3 | 2024 | 2840 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 529 | 0.160 |
Why?
| | Preoperative Period | 1 | 2020 | 148 | 0.160 |
Why?
| | Delphi Technique | 4 | 2025 | 329 | 0.160 |
Why?
| | Patient Care Team | 1 | 2026 | 686 | 0.160 |
Why?
| | Sports | 1 | 2022 | 211 | 0.150 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 14 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 81 | 0.150 |
Why?
| | Benchmarking | 1 | 2021 | 188 | 0.150 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 177 | 0.150 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 7 | 0.150 |
Why?
| | Databases, Factual | 2 | 2016 | 1484 | 0.150 |
Why?
| | Medulloblastoma | 1 | 2022 | 215 | 0.150 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 41 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1782 | 0.150 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 11 | 0.150 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.150 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 40 | 0.150 |
Why?
| | Biomedical Research | 1 | 2025 | 709 | 0.140 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 20 | 0.140 |
Why?
| | Neoplasm Grading | 2 | 2021 | 307 | 0.140 |
Why?
| | Middle Aged | 12 | 2020 | 35762 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1533 | 0.140 |
Why?
| | Cerebellum | 1 | 2020 | 223 | 0.140 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 5 | 0.140 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 9 | 0.140 |
Why?
| | Spinal Curvatures | 1 | 2018 | 7 | 0.140 |
Why?
| | Specialties, Surgical | 1 | 2019 | 81 | 0.140 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 237 | 0.140 |
Why?
| | Phenotype | 2 | 2024 | 3157 | 0.140 |
Why?
| | Bone Transplantation | 1 | 2018 | 85 | 0.140 |
Why?
| | Skull Neoplasms | 1 | 2017 | 21 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 725 | 0.140 |
Why?
| | Survival Rate | 3 | 2026 | 2088 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 124 | 0.130 |
Why?
| | Bone Resorption | 1 | 2018 | 80 | 0.130 |
Why?
| | Cyst Fluid | 1 | 2017 | 20 | 0.130 |
Why?
| | Risk Factors | 7 | 2022 | 10699 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 210 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1510 | 0.130 |
Why?
| | Hypophysitis | 1 | 2017 | 3 | 0.130 |
Why?
| | Fetus | 1 | 2022 | 803 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 356 | 0.130 |
Why?
| | Re-Irradiation | 1 | 2016 | 9 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 582 | 0.130 |
Why?
| | Chloroquine | 1 | 2017 | 53 | 0.130 |
Why?
| | Survival Analysis | 2 | 2023 | 1382 | 0.120 |
Why?
| | Nurses | 1 | 2019 | 178 | 0.120 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 102 | 0.120 |
Why?
| | Patient Admission | 1 | 2018 | 218 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 1953 | 0.120 |
Why?
| | Aged, 80 and over | 4 | 2018 | 8243 | 0.120 |
Why?
| | Glioblastoma | 2 | 2010 | 353 | 0.120 |
Why?
| | Organ Size | 1 | 2017 | 462 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2192 | 0.120 |
Why?
| | Age Factors | 3 | 2020 | 3313 | 0.120 |
Why?
| | Algorithms | 2 | 2022 | 1834 | 0.120 |
Why?
| | Animals | 8 | 2025 | 38030 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2019 | 405 | 0.120 |
Why?
| | Accidents, Traffic | 2 | 2014 | 190 | 0.120 |
Why?
| | Cetirizine | 1 | 2015 | 2 | 0.120 |
Why?
| | Ambrosia | 1 | 2015 | 6 | 0.120 |
Why?
| | Aged | 7 | 2019 | 25850 | 0.120 |
Why?
| | Nasal Sprays | 1 | 2015 | 6 | 0.110 |
Why?
| | Athletic Injuries | 1 | 2022 | 569 | 0.110 |
Why?
| | Fluticasone | 1 | 2015 | 53 | 0.110 |
Why?
| | Amphiregulin | 1 | 2015 | 27 | 0.110 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 25 | 0.110 |
Why?
| | Cataract | 1 | 2018 | 238 | 0.110 |
Why?
| | Cytokines | 3 | 2018 | 2061 | 0.110 |
Why?
| | Radiography | 4 | 2023 | 842 | 0.110 |
Why?
| | Glasgow Coma Scale | 3 | 2026 | 213 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1335 | 0.110 |
Why?
| | Cerebral Veins | 1 | 2014 | 16 | 0.100 |
Why?
| | Logistic Models | 3 | 2019 | 2104 | 0.100 |
Why?
| | Mice | 7 | 2025 | 18329 | 0.100 |
Why?
| | Chromosomes | 2 | 2024 | 108 | 0.100 |
Why?
| | Mutation | 5 | 2025 | 4085 | 0.100 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 10 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2015 | 768 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 13 | 0.100 |
Why?
| | Indoles | 1 | 2017 | 501 | 0.090 |
Why?
| | Sulfonamides | 1 | 2017 | 580 | 0.090 |
Why?
| | Carcinoma | 1 | 2014 | 227 | 0.090 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 10 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.090 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 1129 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 582 | 0.090 |
Why?
| | Cerebral Angiography | 2 | 2014 | 119 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 851 | 0.090 |
Why?
| | Action Potentials | 2 | 2025 | 506 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4556 | 0.090 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 71 | 0.090 |
Why?
| | Urethra | 1 | 2011 | 56 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1322 | 0.090 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 5 | 0.090 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 58 | 0.090 |
Why?
| | Treatment Failure | 2 | 2025 | 363 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1906 | 0.080 |
Why?
| | Umbilicus | 1 | 2011 | 17 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 881 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 2301 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 919 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2011 | 130 | 0.080 |
Why?
| | Brachial Plexus | 1 | 2011 | 35 | 0.080 |
Why?
| | Monitoring, Physiologic | 2 | 2026 | 289 | 0.080 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 6 | 0.080 |
Why?
| | Signal Transduction | 2 | 2025 | 5221 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 120 | 0.080 |
Why?
| | Registries | 3 | 2025 | 2382 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 251 | 0.080 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 103 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1487 | 0.080 |
Why?
| | Radiosurgery | 1 | 2014 | 400 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1347 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2025 | 2494 | 0.070 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.070 |
Why?
| | Prospective Studies | 4 | 2026 | 7970 | 0.070 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 49 | 0.070 |
Why?
| | Zygoma | 1 | 2008 | 7 | 0.070 |
Why?
| | Pia Mater | 1 | 2008 | 4 | 0.070 |
Why?
| | Computer Simulation | 3 | 2021 | 1025 | 0.070 |
Why?
| | Topography, Medical | 1 | 2008 | 11 | 0.070 |
Why?
| | Functional Laterality | 1 | 2009 | 241 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1487 | 0.070 |
Why?
| | Biopsy | 1 | 2011 | 1075 | 0.070 |
Why?
| | Temporal Arteries | 1 | 2008 | 43 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2016 | 1169 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 84 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 107 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 197 | 0.060 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 195 | 0.060 |
Why?
| | Paraganglioma | 1 | 2008 | 53 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2010 | 281 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 338 | 0.060 |
Why?
| | Population Dynamics | 1 | 2008 | 158 | 0.060 |
Why?
| | Recurrence | 1 | 2010 | 1134 | 0.060 |
Why?
| | Injections, Spinal | 1 | 2026 | 120 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2010 | 537 | 0.060 |
Why?
| | Forecasting | 1 | 2008 | 388 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 556 | 0.060 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 279 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 975 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 278 | 0.060 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.060 |
Why?
| | Research Support as Topic | 1 | 2025 | 79 | 0.060 |
Why?
| | Malformations of Cortical Development | 1 | 2025 | 19 | 0.060 |
Why?
| | Cranial Fontanelles | 1 | 2024 | 4 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2026 | 3592 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1098 | 0.050 |
Why?
| | Seizures | 1 | 2008 | 460 | 0.050 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 13 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 222 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2023 | 56 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 70 | 0.050 |
Why?
| | Spinal Cord | 1 | 2026 | 380 | 0.050 |
Why?
| | Heart Atria | 1 | 2024 | 144 | 0.050 |
Why?
| | Stroke | 2 | 2014 | 1254 | 0.050 |
Why?
| | Cranial Irradiation | 1 | 2023 | 85 | 0.050 |
Why?
| | Drug Resistant Epilepsy | 1 | 2025 | 124 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 235 | 0.050 |
Why?
| | Sex Factors | 1 | 2009 | 2096 | 0.050 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 141 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 55 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 75 | 0.040 |
Why?
| | Gene Ontology | 1 | 2021 | 53 | 0.040 |
Why?
| | NF-kappa B | 1 | 2025 | 661 | 0.040 |
Why?
| | Vancomycin | 1 | 2022 | 93 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1332 | 0.040 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 402 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 219 | 0.040 |
Why?
| | Transplants | 1 | 2021 | 39 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 183 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 193 | 0.040 |
Why?
| | Postoperative Care | 1 | 2022 | 288 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1820 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 290 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 516 | 0.040 |
Why?
| | Recovery of Function | 1 | 2024 | 706 | 0.040 |
Why?
| | Chronic Disease | 1 | 2026 | 1812 | 0.040 |
Why?
| | Genes, APC | 1 | 2019 | 11 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 488 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 97 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 127 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 417 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1715 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 112 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 224 | 0.040 |
Why?
| | Critical Care Nursing | 1 | 2019 | 51 | 0.030 |
Why?
| | Electronic Mail | 1 | 2018 | 61 | 0.030 |
Why?
| | Surgical Wound | 1 | 2018 | 27 | 0.030 |
Why?
| | Odontogenesis | 1 | 2018 | 11 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 172 | 0.030 |
Why?
| | Point Mutation | 1 | 2019 | 243 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 29 | 0.030 |
Why?
| | Standard of Care | 1 | 2018 | 80 | 0.030 |
Why?
| | Weight Gain | 1 | 2022 | 556 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2926 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 610 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 83 | 0.030 |
Why?
| | Drug Approval | 1 | 2018 | 89 | 0.030 |
Why?
| | Receptors, HIV | 1 | 2017 | 23 | 0.030 |
Why?
| | Mucin-1 | 1 | 2017 | 22 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 33 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 370 | 0.030 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 47 | 0.030 |
Why?
| | Pituitary Gland | 1 | 2018 | 148 | 0.030 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 55 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1497 | 0.030 |
Why?
| | Canada | 1 | 2018 | 428 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 567 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 117 | 0.030 |
Why?
| | Brain Diseases | 1 | 2018 | 152 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1187 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 606 | 0.030 |
Why?
| | Neuroglia | 1 | 2018 | 172 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 123 | 0.030 |
Why?
| | Prevalence | 2 | 2016 | 2815 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2003 | 736 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 510 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1739 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 928 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 316 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 681 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 321 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 284 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 357 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 7180 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1682 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 532 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1172 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 898 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2111 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 252 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 285 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 45 | 0.030 |
Why?
| | Chicago | 1 | 2013 | 61 | 0.020 |
Why?
| | Body Mass Index | 1 | 2022 | 2420 | 0.020 |
Why?
| | Quality Improvement | 1 | 2022 | 1285 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6021 | 0.020 |
Why?
| | Necrosis | 1 | 2013 | 244 | 0.020 |
Why?
| | History, 19th Century | 1 | 2011 | 61 | 0.020 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 34 | 0.020 |
Why?
| | Germany | 1 | 2011 | 138 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1659 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2870 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2430 | 0.020 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 56 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 132 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 13 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1559 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 324 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1241 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 358 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 60 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 421 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 22 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3057 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 427 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 246 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2877 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5813 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2143 | 0.010 |
Why?
| | New York | 1 | 2003 | 124 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 64 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 124 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3637 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 648 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 1027 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 756 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 916 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 7155 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 2314 | 0.000 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|